SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the creation of the Illumina Genome Network, a global partnership designed to link researchers interested in conducting large-scale whole human genome sequencing projects with leading institutions that can perform such projects using Illumina sequencing. The Genome Network will provide researchers who do not have access to high-quality, next-generation sequencing technology an economical and dependable way to complete their sequencing projects.
